In a nutshell This study examined if GVDex is as effective and safe as GVDoxil for treating Hodgkin's lymphoma (HL) that has come back or stopped responding to treatment. The authors found that GVDex was as effective as GVDoxil, with fewer side effects. Some background For most patients with HL, primary therapy is highly effective....Read More
Hodgkin’s lymphoma Posts on Medivizor
In a nutshell This study investigated how often patients Hodgkin’s lymphoma (HL) experienced blood clots and what factors increased the risk of blood clots. The authors found that patients with advanced HL were more likely to develop blood clots, particularly during chemotherapy, and that age, smoking status, and treatment frequency increased...Read More
Does the modification of chemotherapy reduce heart disease side effects in patients with Hodgkin lymphoma?
In a nutshell This study examined if a modified version of doxorubicin (Adriamycin) in ABVD chemotherapy was safe and effective in patients with Hodgkin’s lymphoma who had heart disease. This study found that this regimen was safer and just as effective as conventional ABVD. Some background Hodgkin’s lymphoma (HL) is a cancer of white...Read More
Searching for participants with high risk relapsed or unresponsive Hodgkin lymphoma to try a treatment combination.
In a nutshell This study will investigate the effects of nivolumab (Opdivo) and brentuximab vedotin (Adcetris) after stem cell transplant in patients with high risk relapsed or refractory Hodgkin lymphoma (RRHL). The main outcome that will be measured is progression-free survival. This trial is recruiting in multiple locations in the United States. The...Read More
In a nutshell This article reviewed how useful PET/CT scanning is for patients with Hodgkin's lymphoma (HL) during and after their treatment. Some background Hodgkin's lymphoma (HL) is a cancer of lymphocytes. Lymphocytes are a type of white blood cell that fights infections in the body. For most patients, first-line treatment is highly...Read More
In a nutshell This study investigated female fertility preservation (FFP) in cancer patients. They found that FFP should be discussed with all women of reproductive age undergoing cancer treatment. Some background Cancer can have many negative effects on patient health. Infertility is a particular concern for younger female patients. Pregnancy rates...Read More
Looking for patients with relapsed or unresponsive classical Hodgkin lymphoma to test a new treatment combination
In a nutshell This study is evaluating how well a new chemoimmunotherapy regimen works in treating patients with classical Hodgkin’s lymphoma (cHL) that has come back or stopped responding to treatment. The main outcome to be measured will be the number of patients who have a complete disappearance of all signs of cancer after treatment. This study...Read More
In a nutshell This article reviewed current treatment options for elderly patients with Hodgkin lymphoma (HL). Some background There are two main types of Hodgkin’s lymphoma. These include classical HL (cHL) and nodular lymphocyte-predominant HL (NLPHL). NLPHL is the rarer of these two types. Chemotherapy and radiation are the foundations...Read More
In a nutshell This article reviewed different options for first-line treatment for Hodgkin lymphoma (HL). Some background Treatment for patients with HL has become more individualized. Treatment strategies have been adapted to disease risk, and how well patients respond to initial treatment. The goal of these approaches is to reduce side effects...Read More
In a nutshell This study looked at the safety and effectiveness of pembrolizumab (Keytruda) in the treatment of patients with relapsed or unresponsive Hodgkin lymphoma after stem cell transplant. Researchers found that pembrolizumab was a safe and effective treatment when used in this way. Some background Hodgkin lymphoma is a cancer of the immune...Read More
In a nutshell This study investigated whether interleukin-2 receptor levels in the blood influenced the outcomes of patients with classical Hodgkin’s lymphoma (cHL). This study concluded that this can be a useful tool for predicting prognosis for these patients. Some background Chemotherapy remains the standard first-line treatment for HL. One...Read More
In a nutshell This article reviewed current treatment options for patients with Hodgkin lymphoma (HL) that has come back (relapsed) or stopped responding to treatment (refractory). Some background Chemotherapy remains the standard first-line treatment for HL. One of the most commonly used regimens is ABVD (doxorubicin, bleomycin, vinblastine,...Read More